Citius Oncology Reports 120% Growth in LYMPHIR Shipments
Preliminary, unaudited fiscal fourth-quarter 2026 sales totaled 792 LYMPHIR units to U.S. wholesalers, up 120% from the prior quarter. Prescribing centers ordered 950 vials, and 54 institutions had ordered LYMPHIR as of October 26.